IMVT-1402-2505: A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease (clinicaltrialsregister.eu) - Jun 6, 2026 - P1/2 | N=128 | Not yet recruiting | Sponsor: Immunovant Sciences GmbH | N=84 ➔ 128
Enrollment change • Endocrine Disorders • Grave's Disease
|